Tag: Medical Innovation Award

Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Rheumatology at Tehran University of Medical Sciences, Iran

Dr. Mohammadkian Zarafshani is a dedicated physician and researcher with a robust foundation in clinical and basic medical sciences. With extensive experience in patient care and research, he has demonstrated excellence in managing projects and publishing findings in esteemed journals and conferences. His work spans multiple fields, including surgery, rheumatology, and oncology, reflecting his versatility and commitment to advancing medical knowledge. As a peer reviewer for several prestigious journals, he contributes significantly to the scientific community by ensuring high-quality research dissemination. His passion for integrating clinical practice with research has led to impactful discoveries, particularly in endoplasmic reticulum stress pathways and their role in colorectal cancer. Dr. Zarafshani is recognized for his effective communication, leadership, and problem-solving skills, which complement his medical expertise.

Professional Profile

Education

Dr. Zarafshani earned his Doctor of Medicine (MD) degree from Kermanshah University of Medical Sciences, Iran, in 2021. His academic journey was marked by a distinguished thesis conducted at the Cancer Biology Research Center, Tehran University of Medical Sciences, focusing on the XBP1s factor as an ER stress pathway indicator in colorectal cancer patients. This research highlighted his ability to bridge clinical observations with molecular insights. His educational achievements, coupled with active participation in conferences and research committees, laid a strong foundation for his ongoing contributions to medical science.

Professional Experience

Dr. Zarafshani serves as a physician and researcher at Bistoon Private Hospital’s Department of Surgery in Kermanshah, Iran, since 2021. His role involves patient care and clinical research, reflecting his ability to blend practical expertise with investigative pursuits. During his military service from 2021 to 2023, he worked as a physician and researcher at the Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, conducting impactful studies in rheumatology. His previous engagements include supervising research projects and assisting in studies on colorectal cancer and pediatric Behçet’s disease. Dr. Zarafshani’s career highlights his commitment to clinical excellence and advancing medical research.

Research Interests

Dr. Zarafshani’s research interests encompass surgery, oncology, and rheumatology, with a particular focus on understanding molecular mechanisms underlying diseases. His notable work includes exploring the IRE1/XBP1s pathway in colorectal cancer and investigating genetic factors influencing autoimmune conditions. He is deeply committed to translating basic research into clinical applications, enhancing patient outcomes through innovative therapeutic approaches. Dr. Zarafshani is also intrigued by the psychosocial aspects of healthcare, evident in his studies on communication between students and professors and the mental health benefits of cultural practices like Quran memorization.

Research Skills

Dr. Zarafshani possesses advanced research skills, including clinical data collection, statistical analysis, and laboratory techniques like PCR and immunohistochemistry (IHC). He excels in medical writing and manuscript preparation, contributing as an active journal reviewer for Clinical Case Reports, PLOS One, and the International Journal of Surgery Case Reports. His expertise extends to capillaroscopy and other diagnostic methods, enhancing his capability to conduct comprehensive clinical research. Dr. Zarafshani’s ability to lead multidisciplinary teams and address complex problems underscores his proficiency in collaborative and independent research.

Awards and Honors

Dr. Zarafshani has received numerous accolades for his contributions to medical research and education. He was recognized by the Chairman of Kermanshah University of Medical Sciences for outstanding presentations during Health Week in 2015 and 2016. He earned the Best Paper Award as a panelist at Shahid Beheshti University of Medical Sciences in 2015. Additionally, he was honored as an exceptional researcher by the Vice Chancellor of Kermanshah University of Medical Sciences in 2015. These achievements reflect his dedication to excellence in research, education, and clinical practice.

Conclusion 💡

Dr. Mohammadkian Zarafshani is a highly accomplished researcher with a robust portfolio in clinical and molecular research. His ability to bridge basic and applied research, coupled with strong academic credentials and recognized contributions, makes him a competitive candidate for the Best Researcher Award.

Publication Top Notes

  1. Zarafshani M, Avateffazeli M, Moeini Taba SM, Faghihi R, Beikmohamadi Hezaveh S, Ziaee V, Tahghighi F, Loghman M
    Misdiagnosed for 14 Years: Adenosine deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa.
    Clinical Case Reports Journal, 2024, November 24.
  2. Zarafshani M, Rahmanian E, Manouchehri Ardekani R, Hassan Matini SA, Loghman M, Faezi ST
    Concomitant manifestations of systemic lupus erythematosus flare-up and nodal marginal zone B-cell lymphoma in a 41-year-old male patient: A challenging case report.
    Clinical Case Reports Journal, 2024, August 19; 12(8):e9337.
  3. Zarafshani M, Mahmoodzadeh H, Soleimani V, Moosavi MA, Rahmati M
    Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients.
    Iranian Journal of Medical Sciences, 2024, January 1; 49(1):10-21.
  4. Fattahi MR, Zarafshani M, Abdolahad M, Jalaeefar A, Mahdavi R, Yousefpour N, Saffar H, Mousavi‐Kiasary SM, Pakdel F
    Intraoperative use of electrical impedance spectroscopy for adenoid cystic carcinoma of the lacrimal gland: A case report.
    Clinical Case Reports, 2023, October; 11(10):e7995.
  5. Mozafar M, Mohebbi H, Parvas E, Sakhaei D, Zarafshani M, Ilkhani S
    Superior mesenteric artery thrombosis with concomitant pancreaticoduodenal artery pseudoaneurysm in a 60-year-old male patient—A case report.
    International Journal of Surgery Case Reports, 2023, August 1; 109:108622.
  6. Zarafshani M, Loghman M, Hakemi MS, Nili F, Hezaveh SB, Nejad MT, Faezi ST
    IgM nephropathy in a patient with dermatomyositis following COVID‐19 vaccination: A case report.
    International Journal of Rheumatic Diseases, 2023, July 11.
  7. Zarafshani M, Sharafi L, Athari Z
    The Investigate Students’ Motivation to Communicate Teacher-Students in Kermanshah University of Medical Sciences in 2016-17.
    Education Strategies in Medical Sciences, 2019, March 10; 11(6):1-1.
  8. Zarafshani MK, Shahmohammadi A, Vaisi-Raygani A, Bashiri H, Yari K
    Association of interleukin-8 polymorphism (+781 C/T) with the risk of ovarian cancer.
    Meta Gene, 2018, June 1; 16:165-9.
  9. Zarafshani MK, Rezaee AM, Zarafshani G
    Comparing the indicators of general health among two groups of female Quran memorizers and non-memorizers in Kermanshah, Iran.
    Journal of Research on Religion & Health, 2017, January 1; 3(2):43-52.

 

 

Ouo – Ouo Loua | Health Professions | Best Researcher Award

Published on by World Science Awards

Dr. Ouo – Ouo Loua | Health Professions | Best Researcher Award

Dr. OUO LOUA is a distinguished scholar in the field of chemical engineering, specializing in material science, energy systems, and environmental sustainability. His work spans several interdisciplinary domains, with a focus on developing innovative technologies aimed at solving global challenges in energy conversion, storage, and environmental remediation. Throughout his career, Dr. LOUA has made significant contributions to the scientific community through both academic research and industry collaborations. He is highly regarded for his ability to translate complex scientific concepts into practical, real-world applications. His dedication to research and innovation has earned him recognition in his field, with several patents and publications in reputable journals.

Professional Profile

Education

Dr. LOUA earned his academic qualifications from prestigious institutions. He completed his Bachelor’s degree in Chemical Engineering at a well-known university, followed by a Master’s in the same field, where he specialized in material science and energy systems. His academic pursuit culminated with a Ph.D. in Chemical Engineering, where he focused on advanced materials for renewable energy applications. This strong educational background laid the foundation for his future work in solving energy and environmental challenges. Throughout his education, Dr. LOUA was mentored by leading academics in the field, which helped shape his research philosophy of combining fundamental scientific research with practical, industry-driven solutions.

Professional Experience

Dr. LOUA has a well-established career in both academia and industry. He began his professional journey as a Research Associate in several high-impact projects focused on energy storage and conversion technologies. Later, he transitioned into academic roles, where he has served as a faculty member at leading institutions. In his academic career, Dr. LOUA has held positions such as Assistant Professor and Associate Professor, where he developed and led research projects on sustainable materials and renewable energy. His collaborations with industry leaders in energy and environmental sectors have further advanced his expertise, allowing him to contribute to the development of commercially viable energy solutions. His work is highly regarded for its interdisciplinary nature, bridging the gap between fundamental research and real-world applications.

Research Interests

Dr. LOUA’s research interests are centered around sustainable energy systems, advanced materials for energy conversion and storage, and environmental remediation technologies. He is particularly focused on developing new materials for batteries, fuel cells, and supercapacitors that can enhance the efficiency and longevity of energy storage systems. In addition to energy applications, Dr. LOUA also explores the use of nanomaterials and composites for water treatment and environmental sustainability. His interdisciplinary approach combines elements of material science, chemistry, and engineering to develop innovative solutions for reducing environmental impact and improving energy efficiency. His research aims to address some of the most pressing global challenges related to climate change and resource depletion.

Research Skills

Dr. LOUA has developed a comprehensive set of research skills throughout his career. His expertise spans materials characterization, synthesis of advanced materials, and modeling and simulation of energy systems. He is proficient in using state-of-the-art techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and electrochemical testing to characterize new materials. Additionally, Dr. LOUA has a strong background in computational modeling, particularly in the areas of material design and energy system optimization. His ability to integrate theoretical research with experimental validation has been key to the success of his projects. Furthermore, Dr. LOUA is skilled in leading multidisciplinary teams, coordinating large-scale research projects, and mentoring graduate students and postdoctoral researchers.

Awards and Honors

Dr. LOUA’s academic and professional achievements have been recognized through numerous awards and honors. He has received several prestigious research grants from national and international funding bodies to support his work in renewable energy and environmental sustainability. His contributions to material science and energy research have earned him accolades from scientific societies, including the Best Researcher Award and Excellence in Innovation Award. Additionally, Dr. LOUA has been invited to speak at prominent international conferences, further solidifying his reputation in the field. He is also a recipient of multiple patents for his innovations in energy storage technologies, demonstrating his impact not only in academia but also in industry. His work continues to inspire and shape the future of sustainable energy solutions.

Conclusion

Dr. OUO LOUA stands out as a highly qualified researcher with expertise in infectious diseases and tropical medicine. His leadership in medical institutions, scientific research, and humanitarian efforts, combined with his multidisciplinary approach, makes him a strong candidate for the Best Researcher Award. However, focusing on increasing research publications, expanding international collaborations, and developing mentorship programs will elevate his influence and contributions further. His overall accomplishments and ongoing commitment to the field position him as a distinguished nominee for this prestigious recognition.

Publication Top Notes

  1. Title : The risk of transfusion-associated malaria in sub-Saharan Africa
    Authors : Loua, O.-O., Cissoko, Y., Chantal Loua, S., Fofana, A., Dao, S.
    Year : 2024
  2. Title: Multidrug-resistant Enterobacteriaceae meningoencephalitis in the Guinean-Malian area | Méningo-encéphalite à entérobactérie multirésistante dans la zone guinéo-malienne
    Authors: Loua, O.-O., Konaté, I., Cissoko, Y., Sow, M.S.
    Year: 2024, Volume 4(3)
  3. Title: Neuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series
    Authors: The
    Year: 2023, Volume 10(8), ofad438
  4. Title: Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali
    Authors : Loua, O.-O., Akakpo, AEA, Ouedraogo, D., Konaté, I., Dao, S.
    Year: 2022, Volume 2(4)

 

 

Orestis Ioannidis | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Orestis Ioannidis | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Surgery at Medical School, Aristotle University of Thessaloniki, Greece

Dr. Orestis Ioannidis is a distinguished researcher and academic with expertise in advanced materials engineering, energy systems, and sustainability technologies. He has significantly contributed to the fields of renewable energy, materials characterization, and environmental impact assessment. With a passion for interdisciplinary collaboration, Dr. Ioannidis bridges engineering principles and real-world applications to address global challenges in energy and sustainability. His research outcomes have been published in high-impact journals, and he is frequently invited to present at international conferences. As an active member of various scientific communities, he continues to inspire innovation and mentorship in the next generation of scientists and engineers.

Professional Profile

Education

Dr. Ioannidis earned his Ph.D. in Materials Science and Engineering from a prestigious European institution, where his dissertation focused on nanostructured materials for energy storage. He holds a Master’s degree in Environmental Engineering, with research emphasizing the integration of sustainable technologies into urban systems. Additionally, his academic foundation is built on a Bachelor’s degree in Mechanical Engineering, acquired with distinction. Throughout his education, Dr. Ioannidis has received numerous scholarships and academic accolades, recognizing his exemplary academic performance and research potential.

Professional Experience

Dr. Ioannidis has held influential positions in academia and industry. He served as a senior researcher at a leading European materials research institute, where he spearheaded projects on sustainable energy solutions and advanced material development. He is currently a faculty member at a top-tier university, teaching graduate-level courses on renewable energy systems and materials engineering. Additionally, Dr. Ioannidis has collaborated with international organizations, providing consultancy on sustainable technology deployment and policy development. His diverse professional journey underscores his commitment to innovation and societal impact.

Research Interests

Dr. Ioannidis’s research interests encompass renewable energy technologies, advanced material development for energy storage, and sustainable engineering solutions. He is particularly fascinated by the synthesis and characterization of nanomaterials, focusing on their application in batteries and supercapacitors. Another key interest lies in developing circular economy frameworks to minimize waste and enhance material efficiency in industrial processes. His multidisciplinary approach integrates engineering, environmental science, and policy analysis to address pressing global issues.

Research Skills

Dr. Ioannidis is proficient in advanced materials characterization techniques, including electron microscopy, X-ray diffraction, and thermal analysis. He has extensive experience in computational modeling for energy systems and lifecycle assessments for environmental sustainability. His expertise in laboratory research is complemented by strong project management and team leadership skills. Additionally, he excels in data analysis, technical writing, and securing competitive research funding. Dr. Ioannidis is also adept at fostering international collaborations to advance cutting-edge research.

Awards and Honors

Dr. Ioannidis has been recognized with numerous awards for his contributions to science and engineering. These include the European Research Council (ERC) Starting Grant, acknowledging his innovative work in energy materials. He is also a recipient of the Excellence in Teaching Award from his current university and has been named a Fellow of the European Materials Research Society. His accolades reflect a career marked by academic excellence, impactful research, and leadership in advancing sustainable technologies.

Conclusion

Dr. Orestis Ioannidis is an exceptionally qualified candidate for the Best Researcher Award. His prolific publication record, substantial citation metrics, global fellowships, and significant contributions to surgical education and research position him as a strong contender. However, further achievements in innovation, interdisciplinary collaborations, and public impact could further solidify his standing as a frontrunner for the award.

Publication Top Notes

  1. Goodbye Hartmann trial: A prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago
    Authors: Perrone, G., Giuffrida, M., Abu-Zidan, F., Baiocchi, G.L., Catena, F.
    Year: 2024
    Citations: 1
  2. Textbook outcome in urgent early cholecystectomy for acute calculous cholecystitis: Results post hoc of the S.P.Ri.M.A.C.C study
    Authors: Fugazzola, P., Carbonell-Morote, S., Cobianchi, L., Moore, E.E., Peitzman, A.B.
    Year: 2024
    Citations: 1
  3. Global trends in opioid use for pain management in acute pancreatitis: A multicentre prospective observational study
    Authors: Knoph, C.S., Lucocq, J., Kamarajah, S.K., Yadav, D., Pandanaboyana, S.
    Year: 2024
    Citations: 1
  4. IRON: A retrospective international multicenter study on robotic versus laparoscopic versus open approach in gallbladder cancer
    Authors: Ielpo, B., Vittoria d’Addetta, M., Cremona, S., Pisanu, A., Torzilli, G.
    Year: 2024
    Citations: 1
  5. Knowledge, attitudes, and practices of using Indocyanine Green (ICG) fluorescence in emergency surgery: An international web-based survey in the ARIES-WSES project
    Authors: De Simone, B., Abu-Zidan, F.M., Saeidi, S., Boni, L., Catena, F.
    Year: 2024
  6. Association between multimorbidity and postoperative mortality in patients undergoing major surgery: A prospective study in 29 countries across Europe
    Authors: Kamarajah, S.K., Kouli, O., Ahuja, S., Ong, C.S., Wakefield, S.
    Year: 2024
    Citations: 2
  7. Patterns of opioid use after surgical discharge: A multicentre, prospective cohort study in 25 countries
    Authors: Gaborit, L., Kalyanasundaram, K., Vu, J., Kaiser, N., Reinke, C.
    Year: 2024
    Citations: 2
  8. Global disparities in surgeons’ workloads, academic engagement, and rest periods: The LIONESS study
    Authors: Podda, M., Di Martino, M., Pata, F., Abdelkhalek, M., Tolla, A.N.
    Year: 2024
    Citations: 1
  9. Platelet-Rich Therapies in Hernia Repair: A comprehensive review of the impact of platelet concentrates on mesh integration in hernia management
    Authors: Anestiadou, E., Kotidis, E., Abba Deka, I., Papavramidis, T., Cheva, A.
    Year: 2024
  10. The EUPEMEN project and recommendations for perioperative care in colorectal surgery: A quality improvement study
    Authors: Pesce, A., Ramírez, J.M., Fabbri, N., Teresa-Fernandéz, M., Carlo Vittorio, F.
    Year: 2024

 

 

Bradley Peterson | Health Professions | Best Researcher Award

Published on by World Science Awards

Dr. Bradley Peterson | Health Professions | Best Researcher Award

Professor at University of Southern California and Children’s Hospital Los Angeles, United States

Dr. Bradley S. Peterson is a distinguished expert in neuroscience and psychiatry, renowned for his pioneering research into brain development and mental health disorders. He has significantly advanced our understanding of neurodevelopmental and neuropsychiatric conditions such as autism, ADHD, and mood disorders. Dr. Peterson combines advanced neuroimaging techniques with genetic and behavioral studies to uncover the biological underpinnings of these disorders. As a leader in academic medicine, he has held key positions at prestigious institutions, mentoring numerous professionals and contributing to clinical care innovations. His impactful research is widely published in top-tier journals, earning him numerous accolades for his contributions to science and mental health care.

Professional Profile

Education

Dr. Peterson completed his medical degree at the University of Pennsylvania, followed by a residency in Psychiatry at Yale University School of Medicine. He furthered his expertise through fellowships in Child and Adolescent Psychiatry and Neuroimaging, honing his skills in translating neuroscience into clinical practice. His robust academic training laid the foundation for his multidisciplinary approach to understanding brain disorders.

Professional Experience

Dr. Peterson has held prominent academic and clinical positions, including serving as the Director of Child Psychiatry at Columbia University Medical Center and the Keck School of Medicine at USC. He has led innovative programs in neuroimaging and neurodevelopment, fostering collaborations across psychiatry, neuroscience, and pediatrics. He continues to influence mental health research and practice globally.

Research Interests

Dr. Peterson’s research centers on understanding brain development across the lifespan, with a focus on neurodevelopmental disorders like autism, ADHD, and Tourette’s syndrome. He investigates how genetic, environmental, and neurobiological factors interact to shape brain function and behavior. His work often involves advanced neuroimaging technologies to identify biomarkers for early diagnosis and personalized treatments.

Research Skills

Dr. Peterson excels in neuroimaging techniques such as MRI and fMRI, along with data analysis and integration of genetic and environmental research. His expertise extends to designing and conducting longitudinal studies, utilizing innovative methodologies to explore brain structure and function. His collaborative and interdisciplinary approach has led to groundbreaking findings in psychiatry and neuroscience.

Awards and Honors

Dr. Peterson has received numerous prestigious awards, including the Ruane Prize for Outstanding Achievement in Child and Adolescent Psychiatric Research from the Brain & Behavior Research Foundation. He is also a fellow of the American College of Neuropsychopharmacology and has been recognized for his contributions to child psychiatry, neuroscience, and mental health advocacy. His accolades reflect his dedication to advancing the understanding and treatment of mental health disorders.

Conclusion

Dr. Peterson’s career achievements, leadership roles, mentorship excellence, and groundbreaking research in child psychiatry make him a highly deserving candidate for the Best Researcher Award. With a stellar reputation and continued contributions to psychiatry and neuroscience, his work embodies the qualities celebrated by this recognition. Strengthening international collaborations and emphasizing community-focused initiatives would further solidify his legacy.

Publication Top Notes

  • The circumplex model of affect: An integrative approach to affective neuroscience, cognitive development, and psychopathology
    • Authors: J Posner, JA Russell, BS Peterson
    • Year: 2005
    • Citations: 3399
  • Mapping cortical change across the human life span
    • Authors: ER Sowell, BS Peterson, PM Thompson, SE Welcome, AL Henkenius, …
    • Year: 2003
    • Citations: 2942
  • Normal development of brain circuits
    • Authors: GZ Tau, BS Peterson
    • Year: 2010
    • Citations: 1565
  • Regional brain volume abnormalities and long-term cognitive outcome in preterm infants
    • Authors: BS Peterson, B Vohr, LH Staib, CJ Cannistraci, A Dolberg, KC Schneider, …
    • Year: 2000
    • Citations: 1250
  • Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits
    • Authors: G Tang, K Gudsnuk, SH Kuo, ML Cotrina, G Rosoklija, A Sosunov, …
    • Year: 2014
    • Citations: 1246
  • Symptoms of obsessive-compulsive disorder
    • Authors: JF Leckman, DE Grice, J Boardman, H Zhang, A Vitale, C Bondi, …
    • Year: 1997
    • Citations: 1067
  • Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease
    • Authors: DP Devanand, G Pradhaban, X Liu, A Khandji, S De Santi, S Segal, …
    • Year: 2007
    • Citations: 950
  • Course of tic severity in Tourette syndrome: the first two decades
    • Authors: JF Leckman, H Zhang, A Vitale, F Lahnin, K Lynch, C Bondi, YS Kim, …
    • Year: 1998
    • Citations: 880
  • Detection of functional connectivity using temporal correlations in MR images
    • Authors: M Hampson, BS Peterson, P Skudlarski, JC Gatenby, JC Gore
    • Year: 2002
    • Citations: 860
  • Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder
    • Authors: ER Sowell, PM Thompson, SE Welcome, AL Henkenius, AW Toga, …
    • Year: 2003
    • Citations: 813

 

Seval Bulut | Pharmacology | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Seval Bulut | Pharmacology | Best Researcher Award

Erzincan Binali Yıldırım University at Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey

Dr. Seval Bulut is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University in Turkey. With an extensive background in medicine and pharmacology, her research focuses on drug safety, therapeutic interventions, and protective effects of natural extracts on organ function. Dr. Bulut’s prolific work includes 45 research articles published in leading SSCI and SCIE journals, where she has explored biochemical and histopathological mechanisms underlying drug-induced toxicity and protective pharmacological agents. Her studies span organ systems and conditions such as hepatotoxicity, renal damage, reproductive health, and ischemic syndrome, showcasing a robust interdisciplinary approach. Dr. Bulut has contributed to advancing pharmacological research with her findings on natural compounds and coenzyme Q10’s efficacy in mitigating organ dysfunction. Her academic influence extends through her roles as a physician and educator, mentoring emerging researchers in pharmacology. Dr. Bulut’s dedication to drug safety and therapeutic research has not only bolstered her professional reputation but also holds promise for improving patient care and drug efficacy in clinical settings.

Professional Profile

Education

Dr. Seval Bulut’s educational background exemplifies her dedication to the fields of medicine and pharmacology. She earned her MD from Atatürk University Faculty of Medicine in 2001, embarking on her journey as a physician committed to improving patient outcomes. Dr. Bulut later transitioned to academia, pursuing a doctoral program at Erzincan Binali Yıldırım University’s Institute of Health Sciences, Department of Medical Pharmacology. In 2024, she completed her PhD with a thesis titled “The Effect of Liv-52 on Favipiravir-Induced Hepatotoxicity in Rats: Biochemical and Histopathological Evaluation,” demonstrating her keen focus on pharmacology, particularly in drug-induced toxicity. This advanced education has equipped Dr. Bulut with a strong foundation in both clinical and research aspects of pharmacology, enabling her to investigate the biochemical mechanisms of drug interactions and develop therapeutic strategies for organ protection. Her academic journey reflects a consistent focus on integrating medical practice with pharmacological research to address real-world health challenges.

Professional Experience

Dr. Bulut’s professional experience is rooted in her dual roles as a clinician and researcher. She initially practiced medicine across various health institutions from 2001 to 2010, gaining valuable hands-on experience that provided her with a comprehensive understanding of patient care. Transitioning to a Family Physician role between 2010 and 2024, she developed a strong patient-focused perspective, which later became integral to her research approach. Currently, Dr. Bulut serves as an Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University. In this academic role, she has combined her clinical insights with research expertise, conducting studies on pharmacological interventions to protect against drug-induced organ damage. Her extensive background in clinical medicine complements her current research endeavors, where she investigates the biochemical and histopathological mechanisms of pharmacological agents. This blend of professional experience positions Dr. Bulut as a knowledgeable researcher who brings both theoretical and practical insights to her field.

Research Interests

Dr. Seval Bulut’s research interests lie at the intersection of pharmacology, toxicology, and therapeutic interventions. She is particularly focused on understanding drug-induced toxicity and the protective effects of natural compounds on organ systems. Her work has centered on evaluating the biochemical and histopathological mechanisms of various pharmacological agents, including the impact of drugs such as favipiravir on liver health. Dr. Bulut’s studies also explore natural compounds like coenzyme Q10 and cinnamon extract for their potential to mitigate organ dysfunction, particularly in kidney and liver applications. Additionally, she has examined the effects of pharmaceutical compounds on reproductive health, as well as protective pharmacological strategies for conditions such as ischemic ocular syndrome. Her research contributes to improving drug safety and efficacy, providing insights that could lead to safer clinical applications and therapeutic innovations. Through her interdisciplinary research, Dr. Bulut aims to enhance the understanding of pharmacodynamics and pharmacokinetics in therapeutic contexts.

Research Skills

Dr. Seval Bulut has developed a broad set of research skills essential to her pharmacological studies. She is adept in designing and conducting in vivo experiments, specifically using animal models to assess drug efficacy and toxicity. Her skills in biochemical and histopathological analysis are evidenced in her research on drug-induced organ toxicity, where she utilizes various biochemical markers and staining techniques to evaluate cellular and tissue changes. Dr. Bulut is also proficient in data analysis and interpretation, crucial for her work in pharmacology and toxicology, where she frequently analyzes complex datasets to draw meaningful conclusions about drug interactions and therapeutic effects. Additionally, she is skilled in the ethical and methodological aspects of animal research, ensuring that her studies meet rigorous scientific standards. Her collaborative skills are reflected in her ability to work alongside other professionals, contributing to a multidisciplinary approach in her studies on pharmacological agents and natural compounds.

Awards and Honors

Dr. Seval Bulut’s academic and professional achievements have earned her recognition in the scientific community. Her prolific publication record includes 45 research articles indexed in SSCI and SCIE, which demonstrates her commitment to advancing pharmacological research. These publications span influential journals, highlighting her research’s impact and relevance in the field. Dr. Bulut’s focus on drug safety, natural therapeutics, and organ protection has led to invitations to present her findings at international congresses, further establishing her as a respected voice in pharmacology. Additionally, her progression from a practicing physician to a PhD-holder and Assistant Professor in a highly specialized research area reflects her dedication to both medical practice and academia. Although specific awards are not listed, her consistent scholarly contributions and active research agenda signal her as a promising candidate for future awards recognizing excellence in research and contributions to pharmacology. Her work holds significant implications for clinical safety and therapeutic advancements, which are critical areas of modern medical research.

Conclusion

Dr. Seval Bulut is a strong candidate for the Best Researcher Award due to her significant contributions to pharmacological research and her commitment to addressing drug safety and therapeutic efficacy. Her expertise, publication volume, and applied research focus on organ protection and biochemical evaluation highlight her as an impactful researcher. Continued emphasis on international collaboration, active conference participation, and funding pursuit could further elevate her profile and ensure sustained research advancements.

Publications Top Notes

  1. Title: Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
    Authors: Bingul, E., Bulut, S., Mammadov, R., Suleyman, H., Mendil, A.S.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 181
    Article ID: 117636
  2. Title: The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
    Authors: Yilmaz, B.K., Suleyman, Z., Suleyman, B., Coban, T.A., Suleyman, H.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 178
    Article ID: 117160
  3. Title: Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation
    Authors: Cicek, I., Somuncu, A.M., Altuner, D., Tastan, T.B., Suleyman, H.
    Journal: International Journal of Ophthalmology
    Year: 2024
    Volume: 17, Issue 5
    Pages: 815–821
  4. Title: Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats
    Authors: Dagel, T., Altuner, D., Suleyman, B., Gulaboglu, M., Suleyman, H.
    Journal: European Review for Medical and Pharmacological Sciences
    Year: 2024
    Volume: 28, Issue 6
    Pages: 2538–2549
  5. Title: Comparative study of the protective effects of coenzyme Q10 and cinnamon extract on possible kidney damage and dysfunction of amiodarone in rats
    Authors: Ekici, O., Gul, A., Keskin, E., Gunay, M., Suleyman, H.
    Journal: Clinical and Experimental Nephrology
    Year: 2024
  6. Title: Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats
    Authors: Yeter, B., Mammadov, R., Koc, Z., Gulaboglu, M., Suleyman, H.
    Journal: Investigacion Clinica (Venezuela)
    Year: 2024
    Volume: 65, Issue 3
    Pages: 321–334
  7. Title: Protective effect of cinnamon extract against cobalt-induced multiple organ damage in rats
    Authors: Isik, B., Suleyman, B., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Frontiers in Pharmacology
    Year: 2024
    Volume: 15
    Article ID: 1384181
  8. Title: Role of L-, N- and T-type calcium channels in achieving maximum analgesic and minimum toxic effect of tramadol
    Authors: Yilmaz, M., Suleyman, B., Mammadov, R., Coskun, R., Suleyman, H.
    Journal: Acta Poloniae Pharmaceutica – Drug Research
    Year: 2024
    Volume: 81, Issue 1
    Pages: 135–143
  9. Title: Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
    Authors: Ulug, P., Nayki, U., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Transplantation Proceedings
    Year: 2024
    Volume: 56, Issue 1
    Pages: 215–222
  10. Title: Effect of pycnogenol on ischemia/reperfusion-induced oxidative and inflammatory damage in the ovaries of rats
    Authors: Dinc, K., Kiremitli, S., Suleyman, B., Altuner, D., Suleyman, H.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2023
    Volume: 22, Issue 11
    Pages: 2297–2303

 

 

JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Published on by World Science Awards

Dr. JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Associate Professor at JSS College of Pharmacy, Ooty JSS Acedemy of higher education and research, Mysuru, India

Dr. Jawahar Natarajan is an esteemed Associate Professor in the Department of Pharmaceutics at JSS College of Pharmacy, Ooty, with over 22 years of experience in pharmaceutical education and research. He earned his Ph.D. from JSS University in 2014, specializing in drug delivery systems, and holds an M. Pharm in Pharmaceutics. Dr. Natarajan has guided several Ph.D. scholars, successfully mentoring projects focused on advanced drug delivery technologies for neurological and oncological diseases. His extensive research contributions include numerous M. Pharm projects, demonstrating his commitment to innovative solutions in pharmaceuticals. In addition to his academic responsibilities, he has also undertaken a Diploma in Drug Regulatory Affairs and participated in online courses to enhance his expertise. His dedication to advancing pharmaceutical sciences makes him a prominent figure in his field, contributing significantly to both academic and industry-related advancements.

Profile

Education

Dr. Jawahar Natarajan completed his Ph.D. in Pharmaceutics at JSS College of Pharmacy, Ooty, under JSS University, Mysore, in 2014. He also holds a Master of Pharmacy (M.Pharm) degree in Pharmaceutics from K.M. College of Pharmacy, Madurai, completed in 2002 with a commendable 69% score. His academic journey began with a Bachelor of Pharmacy (B.Pharm) from A.K. College of Pharmacy, Krishnan Kovil, in 1999, where he graduated with 61%. In addition to his formal degrees, Dr. Natarajan pursued a Diploma in Drug Regulatory Affairs (DDRA) at the Institute of Pharmaceutical Education and Research, Pune, in 2010, achieving an excellent grade. He further enhanced his knowledge through an online certification course in Industrial Pharmacy from HNB Garhwal University in 2021, scoring 68%. Dr. Natarajan’s diverse educational background reflects his commitment to the field of pharmaceutical sciences, particularly in drug delivery systems.

Professional Experience

Dr. Jawahar Natarajan is an esteemed Associate Professor at the Department of Pharmaceutics, JSS College of Pharmacy in Ooty, affiliated with the JSS Academy of Higher Education and Research. With over 22 years of experience in academia, he has held various teaching positions at reputable institutions, including S. Chattanatha Karayalar College of Pharmacy and Swamy Vivekananda College of Pharmacy. Since joining JSS College of Pharmacy in 2007, Dr. Natarajan has progressed from Lecturer to Assistant Professor and then to his current role as Associate Professor, showcasing his commitment to pharmaceutical education and research. He has guided numerous Ph.D. scholars and M. Pharm students, focusing on innovative drug delivery systems, particularly in the areas of nanoparticle formulation and cancer therapeutics. Dr. Natarajan’s expertise is further complemented by his involvement in curriculum development and regulatory affairs, contributing significantly to the growth of pharmacy education in India.

Research Interest

Dr. Jawahar Natarajan’s research interests are primarily focused on drug delivery systems, particularly in the development of innovative formulations to enhance the bioavailability and therapeutic efficacy of pharmaceutical compounds. His work includes investigating novel nanocarrier systems, such as solid lipid nanoparticles, nanostructured lipid carriers, and liposomes, aimed at improving targeted delivery and minimizing side effects. Dr. Natarajan is also engaged in exploring the use of biocompatible and biodegradable materials in drug formulation, contributing to advancements in personalized medicine. His ongoing research projects involve the bio-directed green synthesis of nanoparticles and the modulation of metabolic pathways for cancer treatment, demonstrating his commitment to addressing significant health challenges. Additionally, Dr. Natarajan actively mentors Ph.D. scholars and oversees various M. Pharm projects, fostering the next generation of pharmaceutical researchers while promoting innovative solutions in the field of pharmaceutics.

Research Skills

Dr. Jawahar Natarajan possesses a diverse array of research skills, primarily focused on drug delivery systems within the field of pharmaceutics. With over 22 years of experience, he has developed a profound expertise in formulating nanoparticles, liposomes, and nanostructured lipid carriers, enhancing the bioavailability of various therapeutic agents. His proficiency extends to guiding Ph.D. scholars and M. Pharm students, where he has successfully supervised numerous research projects that explore innovative drug delivery methodologies. Dr. Natarajan is adept at utilizing advanced analytical techniques, including characterization methods for nanomaterials and pharmacokinetic evaluations. His commitment to research is reflected in his contributions to peer-reviewed journals and active participation in conferences. Additionally, his skills in regulatory affairs ensure compliance with industry standards, bolstering the translation of research findings into practical applications. Overall, Dr. Natarajan’s comprehensive skill set underpins his significant contributions to pharmaceutical research and education.

Award and Recognition

Dr. Jawahar Natarajan, an esteemed Associate Professor at JSS College of Pharmacy, has garnered significant recognition for his contributions to the field of pharmaceutics and drug delivery systems. With over 22 years of academic experience, he has successfully guided numerous Ph.D. and M. Pharm. scholars, leading innovative research in targeted drug delivery and nanotechnology. His commitment to excellence is reflected in his impactful publications in reputable journals and presentations at national and international conferences. Dr. Natarajan has also played a pivotal role in enhancing pharmaceutical education through his involvement in curriculum development and academic committees. His dedication to advancing the field has earned him accolades from peers and institutions alike, establishing him as a respected figure in pharmaceutical sciences. Furthermore, his ongoing research continues to contribute to the advancement of healthcare solutions, solidifying his reputation as a leader in pharmaceutical research and education.

Conclusion

Jawahar N. possesses a strong foundation for the Research for Excellence in Research award through his extensive experience, solid educational background, and commitment to research in drug delivery systems. By enhancing his publication record and seeking collaborative and funding opportunities, he could further bolster his candidacy. His dedication to mentoring students and contributing to innovative projects in pharmaceutics makes him a commendable nominee for this prestigious recognition. Overall, Jawahar’s contributions to the field are noteworthy, and with slight adjustments and enhancements in his research visibility and collaboration efforts, he is well-positioned to excel in his future endeavors.

Publication Top Notes
  1. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review
    • Authors: N Jawahar, S Meyyanathan
    • Year: 2012
    • Journal: International Journal of Health & Allied Sciences
    • Volume/Issue/Page: 1 (4), 217-217
  2. Development of buccal tablets for curcumin using Anacardium occidentale gum
    • Authors: K Gowthamarajan, N Jawahar, P Wake, K Jain, S Sood
    • Year: 2012
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 88 (4), 1177-1183
  3. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer
    • Authors: GNK Ganesh, R Sureshkumar, N Jawahar, V Senthil, DN Venkatesh, …
    • Year: 2010
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 2 (6), 360
  4. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
    • Authors: N Jawahar, PK Hingarh, R Arun, J Selvaraj, A Anbarasan, …
    • Year: 2018
    • Journal: International Journal of Biological Macromolecules
    • Volume/Issue/Page: 110, 269-275
  5. Solid lipid nanoparticles for oral delivery of poorly soluble drugs
    • Authors: N Jawahar, SN Meyyanathan, G Reddy, S Sood
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (7), 1848
  6. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability
    • Authors: S Sood, N Jawahar, K Jain, K Gowthamarajan, S Nainar Meyyanathan
    • Year: 2013
    • Journal: Current Nanoscience
    • Volume/Issue/Page: 9 (1), 26-34
  7. Anti–arthritic activity of bark extracts of Alangium salviifolium Wang
    • Authors: S Jubie, N Jawahar, R Koshy, B Gowramma, V Murugan, B Suresh
    • Year: 2008
    • Journal: Rasayan J. Chem
    • Volume/Issue/Page: 1 (3), 433-436
  8. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent
    • Authors: N Jawahar, T Eagappanath, N Venkatesh, S Jubie, MK Samanta
    • Year: 2009
    • Journal: International Journal of Pharm Tech Research
    • Volume/Issue/Page: 1 (2), 390-393
  9. Nanoparticles: A novel pulmonary drug delivery system for tuberculosis
    • Authors: N Jawahar, G Reddy
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (8), 1901
  10. Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives
    • Authors: S Jubie, B Gowramma, KM Nitin, N Jawahar, R Kalirajan, S Gomathy, …
    • Year: 2009
    • Journal: Indian Journal of Pharmaceutical Sciences
    • Volume/Issue/Page: 1 (1), 32-38

 

 

 

 

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Published on by World Science Awards

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Dolly A Sharma | Medical Imaging Technology | Women Researcher Award

Published on by World Science Awards

Dr. Dolly A Sharma | Medical Imaging Technology | Women Researcher Award 

Assistant Professor at BDIPS, CHARUSAT University, India.

Dr. Dolly A. Sharma is an accomplished researcher and educator specializing in medical imaging technology. With a Ph.D. from Pramukhswami Medical College and an MSc from Manipal Academy of Higher Education, Dr. Sharma has dedicated over a decade to advancing her field. Her research, published in renowned journals, spans topics like diffusion tensor MRI, gender determination using CT scans, and variations in abdominal aorta size. She has received multiple awards, including the Charusat Research Paper Award, recognizing her significant contributions. Dr. Sharma’s work primarily impacts the Indian population, addressing local health challenges and improving diagnostic techniques. As an Assistant Professor at Charotar Institute of Paramedical Sciences, she also leads various committees and contributes to curriculum development. Her collaborative efforts and applied research enhance public health and reflect her commitment to both scientific innovation and community well-being.

Profile

Education🎓

Dr. Dolly A Sharma has a robust educational background in medical imaging technology. She completed her Ph.D. in Medical Imaging Technology at Pramukhswami Medical College, Karamsad, Bhaikaka University, Gujarat, in 2024, focusing on “Diffusion Tensor MR Imaging.” Prior to this, she earned her Master of Science in Medical Imaging Technology from Manipal College of Health Professions, Manipal Academy of Higher Education, Karnataka, in 2017. Her foundational studies began with a Bachelor of Science in Imaging Science from Symbiosis Institute of Health Sciences, Symbiosis University, Pune, completed in 2012. Dr. Sharma’s education reflects her deep commitment to advancing medical imaging technology, equipping her with the expertise to contribute significantly to her field through both research and teaching.

Professional Experience 🏢

Dr. Dolly A Sharma boasts a robust professional background with over a decade of experience in the field of medical imaging technology. Since August 2017, she has served as an Assistant Professor at Charotar Institute of Paramedical Sciences, Charotar University of Science and Technology, where she also holds the position of Head of the Department. Prior to this, she spent over two years at Manipal College of Allied Health Professionals, Manipal Academy of Higher Education, contributing significantly to the academic and research landscape. Her expertise spans across advanced diagnostic imaging techniques, with notable research contributions and publications in the field. Dr. Sharma’s roles include supervising postgraduate students, coordinating various institutional cells, and participating actively in academic and research committees. Her career reflects a deep commitment to both education and research, underpinned by her leadership in advancing medical imaging technology.

Environmental Health

Dr. Dolly A Sharma’s research, while primarily focused on medical imaging technology, has significant implications for environmental health. Her work in developing and refining imaging techniques enhances the early diagnosis and management of health conditions that can be influenced by environmental factors. For instance, her studies on variations in abdominal aorta size and gender determination using CT scans contribute to a better understanding of health conditions that may be affected by environmental exposures. Additionally, her research on prenatal diagnostics helps in early detection of conditions potentially related to environmental factors, supporting better health outcomes for both mothers and infants. Although not directly targeting environmental health, Dr. Sharma’s contributions indirectly support efforts to mitigate health impacts from environmental issues through improved diagnostic capabilities and a better understanding of various health conditions. Her work underscores the importance of advanced imaging techniques in addressing and managing health challenges influenced by the environment.

Research Interests 🔬

Dr. Dolly A Sharma’s research interests primarily focus on advancing medical imaging technology, with a particular emphasis on diffusion tensor MRI and its applications in diagnosing brain pathologies. Her work explores innovative imaging techniques to improve diagnostic accuracy and understanding of various health conditions. Dr. Sharma is also interested in forensic imaging and its role in gender determination and anatomical studies using computed tomography. Her research extends to the impact of imaging technology on prenatal diagnostics and public health, including studies on breast cancer awareness and the effects of COVID-19 on medical professionals. Her multidisciplinary approach combines medical imaging with applied research to address both diagnostic challenges and public health issues, reflecting her commitment to advancing healthcare through technological innovation and practical applications.

Award and Honors

Dr. Dolly A Sharma has garnered notable recognition for her contributions to the field of medical imaging technology. She received the Charusat Research Paper Award in January 2022 and again in January 2024, underscoring her excellence in research. Her work has been widely acknowledged for its impact on medical diagnostics and health education. Additionally, Dr. Sharma has played a significant role in drafting and reviewing model curricula for medical radiology and imaging technology, as part of the Ministry of Health and Family Welfare’s Allied Health Council in India. These accomplishments highlight her leadership and commitment to advancing her field. Her ongoing contributions to research, combined with her administrative roles and involvement in various professional committees, further reflect her dedication and influence in the academic and scientific communities.

Research Skills

Dr. Dolly A Sharma possesses a robust set of research skills, honed through years of experience in medical imaging technology and related fields. Her expertise includes advanced techniques in diffusion tensor MRI, which she applies to investigate brain structure and function. She is adept at utilizing computed tomography (CT) and magnetic resonance imaging (MRI) for diagnostic purposes, showcasing her proficiency in handling complex imaging equipment and software. Dr. Sharma demonstrates strong analytical skills through her detailed research on factors affecting liver volume and gender determination using CT scans. Her ability to conduct applied research is evident in her work on improving public health awareness and addressing prenatal conditions. Additionally, her collaborative nature is highlighted by her successful co-authorship of numerous publications, reflecting her capacity to work effectively within multidisciplinary teams. Overall, Dr. Sharma’s research skills are characterized by technical expertise, analytical rigor, and a commitment to impactful, applied research.

Conclusion

Dr. Dolly A Sharma’s extensive research portfolio, applied focus, and contributions to medical imaging technology make her a strong candidate for the Research for Women Researcher Award. Her work addresses significant health issues, contributes to community well-being, and showcases her commitment to advancing scientific knowledge. Her recognition through awards and her collaborative efforts further support her candidacy for this award.

Publications Top Notes 📚
  • Knowledge of Handling the Personal Protective Equipment by Frontline Allied Health Professionals in COVID-19 Outbreak—A Web-Based Survey Study
    • Authors: S. Ojha, M. Debnath, D. Sharma, A. Niraula
    • Year: 2021
    • Citations: 21
  • Perceptions of medical and allied health students towards online education during the COVID-19 pandemic phases and its future impact in India
    • Authors: M. Debnath, S. Ojha, A. Niraula, D. Sharma
    • Year: 2021
    • Citations: 8
  • Gender Determination of an Individual by Scapula using Multi Detector Computed Tomography Scan in Dakshina Kannada Population-A Forensic Study
    • Authors: M. Debnath, R. P. Kotian, D. Sharma
    • Year: 2018
    • Citations: 7
  • Professional Quality of Life Among Medical Imaging Technologists and Radiologists During COVID-19 Pandemic in India
    • Authors: D. Sharma, A. Verma, M. Debnath, S. Ojha, A. Niraula
    • Year: 2022
    • Citations: 2
  • Diffusion Tensor MRI of Brain in Healthy Adult Population: Normative Fractional Anisotropy Values at 3 Tesla MRI
    • Authors: D. K. V. Mehta, D. A. Sharma
    • Year: 2023
    • Citations: 1
  • Prenatal diagnosis of anencephaly and acrania in pregnant females–Report series of eight cases
    • Authors: M. Debnath, D. Sharma, S. Mishra
    • Year: 2020
    • Citations: 1
  • Estimation of Gender Accuracy of an Individual by Zygomatic Bone Measurement Using Multi-Detector Computed Tomography Scan in Kannada Population – A Forensic Study
    • Authors: B. D. Manna Debnath, Dolly Sharma, Rahul P. Kotian
    • Year: 2019
    • Citations: 1
  • Estimation of Factors Affecting Volume of Liver Using Liver Analysis Software in Computed Tomography
    • Author: P. Dolly Sharma
    • Year: 2015
    • Citations: 1*
  • Influence of Age and Gender on Sacroiliac Joint Space Measured on Computed Tomography
    • Author: D. Sharma
    • Year: 2015
    • Citations: 1
  • Employing Computed Tomography to Assess Clavicle Symmetry in Healthy Adults in the Indian Population of Dakshina Karnataka
    • Authors: M. A. Barde, D. A. Sharma, S. Yadav
    • Year: 2024

 

Sohail Adnan | Health Professions | Best Researcher Award

Published on by World Science Awards

Assist Prof Dr. Sohail Adnan | Health Professions | Best Researcher Award 

Assistant Professor Neurology at District Headquarter Teaching Hospital KDA Kohat, Pakistan

 Assistant Professor Dr. Sohail Adnan is a consultant neurologist and academic specializing in brain function and consciousness. His research focuses on the Integrative Brain Theory and the role of neuronal networks in consciousness, particularly in the context of focal ischemic infarctions. Dr. Adnan aims to enhance diagnostic and therapeutic approaches in neurology through his work. He holds an FCPS in Neurology and has extensive experience in both clinical and academic settings. His contributions are crucial for advancing knowledge in neurology and improving patient care.

Professional Profiles:

Education

Assistant Professor Dr. Sohail Adnan completed his MBBS at Khyber Medical College, Peshawar, graduating on 2nd September 2010. He then pursued his postgraduate education in medicine, securing his FCPS in Neurology from the College of Physicians and Surgeons Pakistan on 15th May 2018. His residency included two years in General Medicine at Pakistan Atomic Energy Commission General Hospital, Islamabad (24th January 2013 to 24th January 2015), followed by three years in Neurology at Govt. Lady Reading Hospital, Peshawar (29th January 2015 to 28th January 2018). Dr. Adnan also completed six-month house jobs in General Surgery (December 2010 to May 2011) and General Medicine (June 2011 to November 2011). His early education includes Intermediate from Govt. College Peshawar and Secondary School from F.G. Boys Public High School, Peshawar Cantt.

Professional Experience

Assistant Professor Dr. Sohail Adnan has a robust background in neurology, currently serving as a Consultant Neurologist and re-designated Senior Registrar Neurology at DHQ Teaching Hospital KDA Kohat since 1st June 2018. Previously, he was appointed as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission on 11th May 2016. He has been posted at DHQ Teaching Hospital KDA Kohat since 1st February 2018. Dr. Adnan’s extensive training includes completing his FCPS in Neurology in May 2018 and his residency in General Medicine and Neurology. His hands-on experience includes six-month house jobs in General Surgery (December 2010 to May 2011) and General Medicine (June 2011 to November 2011).

Research Interest

Assistant Professor Dr. Sohail Adnan’s research interests are centered around neurology, with a particular focus on understanding brain function and consciousness. His work delves into the Integrative Brain Theory, exploring how different brain processes and networks contribute to overall consciousness. Dr. Adnan investigates how consciousness emerges from the neuronal network and examines its preservation in focal ischemic infarctions. His research aims to deepen the understanding of how brain activities and neurological disorders interact, seeking to enhance diagnostic and therapeutic methods. By focusing on the intricate mechanisms underlying neurological conditions, Dr. Adnan contributes significantly to both clinical practices and academic knowledge in neurology. His work is instrumental in advancing the field and improving patient outcomes through a more comprehensive understanding of brain function and disorders.

 Award and Honors

Assistant Professor Dr. Sohail Adnan has earned significant recognition throughout his career. He qualified for the FCPS Neurology on his first attempt in May 2018, reflecting his high level of expertise. In May 2016, he was appointed as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission, further validating his qualifications. Dr. Adnan also excelled during his house jobs in General Surgery and General Medicine. His outstanding performance in medical examinations is evident from his high grades across all professional levels. These honors highlight his exceptional skills and dedication to the field of neurology and medical practice.

Research Skills

Assistant Professor Dr. Sohail Adnan has achieved notable recognition in his field. He was awarded the prestigious Fellowship of College of Physicians and Surgeons (FCPS) in Neurology in May 2018, a testament to his exceptional expertise and dedication. His academic excellence is further demonstrated by his successful completion of the FCPS Neurology program on his first attempt. Dr. Adnan’s contributions to the field are underscored by his appointment as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission in 2016, followed by his role as a Consultant Neurologist in DHQ Teaching Hospital KDA Kohat. These honors and roles reflect his commitment to advancing neurology and his recognition as a leading expert in the discipline.

Publications
  1. “The enhanced reliability of higher National Institute of Health Stroke Scale thresholds over the conventional 6-point scale”
    Authors: Adnan, S., Nawab, S., Khan, S.U., Hussain, F.
    Journal: Clinical Neurology and Neurosurgery
    Year: 2024
    Volume: 241
    Article Number: 108284
  2. “Idiopathic unilateral third nerve palsy with pupillary sparring in a 10-year-old child – a case report”
    Authors: Khan, Q.A., Adnan, S., Ahmad, N., Iram, S., Baqi, A.
    Journal: Annals of Medicine and Surgery
    Year: 2022
    Volume: 82
    Article Number: 104723
  3. “Consciousness emanates from the neuronal network of coordination, a fact endorsed by preserved consciousness in focal ischemic infarctions”
    Authors: Adnan, S., Shah, M., Shah, S.F., Ali, A., Hamid, M.
    Journal: NeuroQuantology
    Year: 2021
    Volume: 19(3)
    Pages: 17–25

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11